Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Butanone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115572744B reveals enzyme catalysis for 1,4-dihydroxy-2-butanone. Offers green sustainable manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN115975969B reveals advanced transaminase mutants for Sitagliptin. Achieve high conversion and stereoselectivity for reliable pharmaceutical intermediate supply chains.
Novel demethylation process ensures greater than 99.5 percent purity. Reduced polymerization offers significant cost and supply chain advantages for global flavor manufacturers seeking reliable partners.
Novel CO2 fixation method for 4 5 dimethyl 1 3 dioxole 2 ketone offers safer greener pharmaceutical intermediate manufacturing with high purity and scalability.
Patent CN112979523A details a novel chiral metal complex catalyzing asymmetric Mukaiyama aldol reactions for high-purity pharmaceutical intermediates with reduced costs.
Novel catalytic demethylation method ensures high purity raspberry ketone with reduced polymerization for cost reduction in flavor manufacturing.
Patent CN108358871B reveals a high-yield synthesis for Photoinitiator 369 intermediates, offering significant cost reduction and safer manufacturing conditions for UV curing materials.
Patent CN114315760A details a sulfuric acid-assisted chlorination method for 2-chloro-1-(4-morpholinylphenyl)-1-butanone, offering superior selectivity and cost efficiency for photoinitiator manufacturing.
Patent CN113061594A reveals novel immobilized transaminase mutants for sitagliptin synthesis, offering superior stability in aqueous isopropanol and reduced manufacturing costs.
Patent CN113666814B details a two-step catalytic method ensuring high purity raspberry ketone with recyclable byproducts for cost-effective flavor manufacturing.
Patent CN104651243B details high-yield biocatalytic synthesis of (R)-1,3-butanediol. Offers superior purity and cost-effective supply chain solutions for antibiotic manufacturing.
Patent CN109749968B reveals a novel Bacillus velezensis strain for synthesizing chiral intermediates. This breakthrough offers significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN100567497C details a novel two-phase enzymatic route for high-purity chiral 2-butanol. This method offers significant supply chain stability and cost reduction advantages.
Discover how TEMPO/TBN catalysis enables room-temperature N-alkylation with 83% yield, eliminating oxidation agents and reducing supply chain risks for pharmaceutical intermediates.